A nodular cutaneous lymphoproliferative disorder during carbamazepine administration.
Sigal-Nahum
M
M
Petit
A
A
Gaulier
A
A
Torrent
J
J
Mourier
C
C
Karmochkine
M
M
D002220:Carbamazepine / Q000009:adverse effects*; D006801:Humans; D008232:Lymphoproliferative Disorders / Q000139:chemically induced*; D008297:Male; D008875:Middle Aged; D012536:Scalp Dermatoses / Q000139:chemically induced*; D012872:Skin Diseases, Vesiculobullous / Q000139:chemically induced*
D002220:Carbamazepine